Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042

Aaron S. Mansfield, Roy S. Herbst, Gilberto de Castro, Rina Hui, Nir Peled, Dong Wan Kim, Silvia Novello, Miyako Satouchi, Yi Long Wu, Edward B. Garon, Martin Reck, Andrew G. Robinson, Ayman Samkari, Bilal Piperdi, Victoria Ebiana, Jianxin Lin, Tony S.K. Mok

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Article number100205
JournalJTO Clinical and Research Reports
Volume2
Issue number8
DOIs
StatePublished - Aug 2021

Fingerprint

Dive into the research topics of 'Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042'. Together they form a unique fingerprint.

Cite this